John Wiley & Sons, Inc. (WLYB) stock
Close on Oct 30, 2026Market cap $2.62BP/E 13.9Yield –
Earnings
John Wiley & Sons's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Quarterly results
Revenue and earnings per share from each of John Wiley & Sons's earnings releases, newest first
| Quarter | Reported | Revenue | YoY | EPS | Adj. EPS | Source |
|---|---|---|---|---|---|---|
| Q2 FY2027ended Oct 31, 2026 | Dec 3, 2026Expected | – | – | – | – | – |
| Q1 FY2027ended Jul 31, 2026 | Sep 3, 2026before the open | $386.00M | -2.8% | -$0.23 | $0.44 | Release |
| Q4 FY2026ended Apr 30, 2026 | Jun 16, 2026during market hours | $448.00M | +1.1% | $2.61 | $1.67 | Release |
| Q3 FY2026ended Jan 31, 2026 | Mar 5, 2026during market hours | $410.00M | +1.2% | $0.56 | $0.97 | Release |
| Q2 FY2026ended Oct 31, 2025 | Dec 4, 2025during market hours | $422.00M | -1.2% | $0.84 | $1.10 | Release |
| Q1 FY2026ended Jul 31, 2025 | Sep 4, 2025during market hours | $397.00M | -1.7% | $0.22 | $0.49 | Release |
| Q4 FY2025ended Apr 30, 2025 | Jun 17, 2025during market hours | $443.00M | -5.3% | $1.25 | $1.37 | Release |
| Q3 FY2025ended Jan 31, 2025 | Mar 6, 2025during market hours | $405.00M | -12.1% | -$0.43 | $0.84 | Release |
| Q2 FY2025ended Oct 31, 2024 | Dec 5, 2024during market hours | $427.00M | -13.4% | $0.74 | $0.97 | Release |
| Q1 FY2025ended Jul 31, 2024 | Sep 5, 2024during market hours | $404.00M | -10.4% | -$0.03 | $0.47 | Release |
| Q4 FY2024ended Apr 30, 2024 | Jun 13, 2024during market hours | $468.00M | -11.0% | $0.46 | $1.21 | Release |
| Q3 FY2024ended Jan 31, 2024 | Mar 7, 2024during market hours | $461.00M | -6.1% | -$2.08 | $0.59 | Release |
| Q2 FY2024ended Oct 31, 2023 | Dec 6, 2023during market hours | $493.00M | -4.3% | -$0.35 | $0.73 | Release |
| Q1 FY2024ended Jul 31, 2023 | Sep 7, 2023during market hours | $451.00M | -7.6% | -$1.67 | $0.27 | Release |
| Q4 FY2023ended Apr 30, 2023 | Jun 15, 2023during market hours | $526.00M | -3.7% | $1.22 | $1.45 | Release |
| Q3 FY2023ended Jan 31, 2023 | Mar 9, 2023during market hours | $491.00M | -4.8% | -$1.29 | $0.85 | Release |
| Q2 FY2023ended Oct 31, 2022 | Dec 7, 2022during market hours | $515.00M | -3.4% | $0.68 | $1.20 | Release |
| Q1 FY2023ended Jul 31, 2022 | Sep 7, 2022during market hours | $488.00M | – | -$0.32 | $0.36 | Release |
| Q4 FY2022ended Apr 30, 2022 | Jun 15, 2022during market hours | $546.00M | – | $0.76 | $1.08 | Release |
| Q3 FY2022ended Jan 31, 2022 | Mar 8, 2022during market hours | $516.00M | – | $0.63 | $0.95 | Release |
| Q2 FY2022ended Oct 31, 2021 | Dec 7, 2021during market hours | $533.00M | – | $0.99 | $1.29 | Release |
| Q1 FY2022ended Jul 31, 2021 | Sep 2, 2021during market hours | – | – | – | – | Filing |
| Q4 FY2021ended Apr 30, 2021 | Jun 10, 2021during market hours | – | – | – | – | Filing |
| Q3 FY2021ended Jan 31, 2021 | Mar 4, 2021during market hours | – | – | – | – | Filing |
| Q2 FY2021ended Oct 31, 2020 | Dec 8, 2020during market hours | – | – | – | – | Filing |
| Q1 FY2021ended Jul 31, 2020 | Sep 3, 2020during market hours | – | – | – | – | Filing |
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Current guidance
John Wiley & Sons's latest outlook for periods it has not reported yet, compared with what it said before
| Metric | Period | Guidance | Before | Change | Given |
|---|---|---|---|---|---|
| Adjusted EBITDA Marginnon-GAAP | FY2027 | 26.5% – 27.5% | 26.5% – 27.5% | Reaffirmed | Sep 3, 2026 |
| Adjusted EPSnon-GAAP | FY2027 | $4.60 – $5.05 | $4.60 – $5.05 | Reaffirmed | Sep 3, 2026 |
| Free Cash Flownon-GAAP | FY2027 | $205.00M | $205.00M | Reaffirmed | Sep 3, 2026 |
Guidance vs results
The last range John Wiley & Sons gave before each report, against the figure it then reported. Full years add up the four quarters.
| Period | Metric | Guidance | Actual | Result |
|---|---|---|---|---|
| FY2026 | Adj. EPS | $3.90 – $4.35 | $4.23Σ4Q | Within range |
| FY2025 | Adj. EPS* | $3.25 – $3.60 | $3.65Σ4Q | Above range |
| FY2025 | Revenue | $1.65B – $1.69B | $1.68BΣ4Q | Within range |
Guidance history
Every forecast John Wiley & Sons put in an earnings release, newest first
| Given | Metric | Period | Guidance | Change |
|---|---|---|---|---|
| Sep 3, 2026 | Adjusted EPS | FY2027 | $4.60 – $5.05 | Reaffirmed |
| Sep 3, 2026 | Free Cash Flow | FY2027 | $205.00M | Reaffirmed |
| Sep 3, 2026 | Adjusted EBITDA Margin | FY2027 | 26.5% – 27.5% | Reaffirmed |
| Jun 16, 2026 | Adjusted EPS | FY2027 | $4.60 – $5.05 | New |
| Jun 16, 2026 | Free Cash Flow | FY2027 | $205.00M | New |
| Jun 16, 2026 | Adjusted EBITDA Margin | FY2027 | 26.5% – 27.5% | New |
| Jun 17, 2025 | Adj. EPS | FY2026 | $3.90 – $4.35 | New |
| Jun 17, 2025 | Free Cash Flow | FY2026 | $200.00M | Reaffirmed |
| Jun 17, 2025 | Adj. EBITDA Margin | FY2026 | 25.5% – 26.5% | New |
| Mar 6, 2025 | Adj. EBITDA* | FY2025 | $385.00M – $410.00M | New |
| Mar 6, 2025 | Adj. EPS* | FY2025 | $3.25 – $3.60 | New |
| Mar 6, 2025 | Free Cash Flow | FY2025 | $125.00M | New |
| Mar 6, 2025 | Free Cash Flow | FY2026 | $200.00M | New |
| Mar 6, 2025 | Adj. Revenue* | FY2025 | $1.65B – $1.69B | New |
| Sep 5, 2024 | capex | FY2025 | $130.00M | Reaffirmed |
| Sep 5, 2024 | Adj. EBITDA* | FY2025 | $385.00M – $410.00M | Reaffirmed |
| Sep 5, 2024 | Adj. EPS* | FY2025 | $3.25 – $3.60 | Reaffirmed |
| Sep 5, 2024 | Free Cash Flow | FY2025 | $125.00M | Reaffirmed |
| Sep 5, 2024 | Adj. Revenue* | FY2025 | $1.65B – $1.69B | Reaffirmed |
| Jun 13, 2024 | capex | FY2025 | $130.00M | New |
| Jun 13, 2024 | Adj. EBITDA* | FY2025 | $385.00M – $410.00M | New |
| Jun 13, 2024 | Adj. EPS* | FY2025 | $3.25 – $3.60 | New |
| Jun 13, 2024 | Free Cash Flow | FY2025 | $125.00M | New |
| Jun 13, 2024 | Adj. Revenue* | FY2025 | $1.65B – $1.69B | New |
| Mar 7, 2024 | Adjusted EBITDA | FY2024 | $335.00M – $355.00M | Raised |
| Mar 7, 2024 | Adjusted EPS | FY2024 | $2.45 – $2.65 | Raised |
| Mar 7, 2024 | Free Cash Flow | FY2024 | $100.00M | New |
| Mar 7, 2024 | Adjusted Revenue | FY2024 | $1.58B – $1.63B | Reaffirmed |
| Dec 6, 2023 | Adjusted EBITDA | FY2024 | $305.00M – $330.00M | Reaffirmed |
| Dec 6, 2023 | Adjusted EPS | FY2024 | $2.05 – $2.40 | Reaffirmed |
| Dec 6, 2023 | Adjusted Revenue | FY2024 | $1.58B – $1.63B | Reaffirmed |
| Sep 7, 2023 | Adjusted EBITDA | FY2024 | $305.00M – $330.00M | Reaffirmed |
| Sep 7, 2023 | Adjusted EPS | FY2024 | $2.05 – $2.40 | Reaffirmed |
| Sep 7, 2023 | Adjusted Revenue | FY2024 | $1.58B – $1.63B | Reaffirmed |
| Jun 15, 2023 | Adjusted EBITDA | FY2024 | $305.00M – $330.00M | New |
| Jun 15, 2023 | Adjusted EPS | FY2024 | $2.05 – $2.40 | New |
| Jun 15, 2023 | Adjusted Revenue | FY2024 | $1.58B – $1.63B | New |
| Mar 9, 2023 | Adjusted EBITDA | FY2023 | $395.00M – $410.00M | Lowered |
| Mar 9, 2023 | Adjusted EPS | FY2023 | $3.30 – $3.55 | Lowered |
| Mar 9, 2023 | Free Cash Flow | FY2023 | $160.00M – $185.00M | Lowered |
| Mar 9, 2023 | Revenue | FY2023 | $2.01B – $2.03B | Lowered |
| Mar 9, 2023 | Revenue | FY2023 | $2.07B – $2.09B | Lowered |
| Sep 7, 2022 | Adjusted EBITDA | FY2023 | $425.00M – $450.00M | Raised |
| Sep 7, 2022 | Adjusted EPS | FY2023 | $3.70 – $4.05 | Raised |
| Sep 7, 2022 | Free Cash Flow | FY2023 | $210.00M – $235.00M | Raised |
| Sep 7, 2022 | Revenue | FY2023 | $2.13B – $2.17B | Raised |
| Sep 7, 2022 | Revenue At constant currency | FY2023 | $2.18B – $2.22B | New |
| Jun 15, 2022 | capex | FY2023 | $115.00M – $125.00M | New |
| Jun 15, 2022 | Adjusted EBITDA | FY2023 | $400.00M – $425.00M | New |
| Jun 15, 2022 | Adjusted EPS | FY2023 | $3.40 – $3.75 | New |
| Jun 15, 2022 | Free Cash Flow | FY2023 | $185.00M – $210.00M | New |
| Jun 15, 2022 | adjusted effective tax rate | FY2023 | 22% – 23% | New |
| Jun 15, 2022 | Revenue | FY2023 | $2.10B – $2.14B | New |
| Mar 8, 2022 | Adjusted EBITDA | FY2022 | $415.00M – $435.00M | Reaffirmed |
| Mar 8, 2022 | Adjusted EPS | FY2022 | $4.00 – $4.25 | Reaffirmed |
| Mar 8, 2022 | Free Cash Flow | FY2022 | $200.00M – $220.00M | Reaffirmed |
| Mar 8, 2022 | Revenue | FY2022 | $2.07B – $2.10B | New |
| Dec 7, 2021 | Adjusted EBITDA | FY2022 | $415.00M – $435.00M | New |
| Dec 7, 2021 | Adjusted EPS | FY2022 | $4.00 – $4.25 | New |
| Dec 7, 2021 | Free Cash Flow | FY2022 | $200.00M – $220.00M | New |
| Dec 7, 2021 | Revenue | FY2022 | $2.07B – $2.10B | New |
Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.
Press releases
Releases John Wiley & Sons filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Results
- News
- Results
- Results
- Update
- Update
- Results
- Results
- News
- Results
- Results
- Results
- Results
- News